Lissette Maria Cespedes, MD | |
185 S Orange Ave, Msb I588, Newark, NJ 07103-2757 | |
(973) 972-3479 | |
Not Available |
Full Name | Lissette Maria Cespedes |
---|---|
Gender | Female |
Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
Location | 185 S Orange Ave, Newark, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003238817 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 25MA09531800 (New Jersey) | Secondary |
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA09531800 (New Jersey) | Primary |
Entity Name | University Physician Associates Of New Jersey Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760492367 PECOS PAC ID: 9830003417 Enrollment ID: O20031118000289 |
News Archive
Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (IS). The goal of the ISWG is to improve patient outcomes by creating protocols that educate pediatricians on early diagnosis and treatment options. Full details of this study appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
In today's headlines, reports that New York seniors are experiencing reduced prescription coverage and more California patients are being added to the health insurance rolls.
Ashoka and Boehringer Ingelheim announced today that they will launch a three-year global initiative to improve health in communities around the world. The "Making More Health" initiative will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems.
Scientists at the Research Institute of McGill University Health Centre have discovered a new genetic mutation linked to osteonecrosis of the hip, specifically the femoral head - the spherical-shaped mass at the top of the femur.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Lissette Maria Cespedes, MD 1852 Long Ter, Union, NJ 07083-5405 Ph: (201) 988-7076 | Lissette Maria Cespedes, MD 185 S Orange Ave, Msb I588, Newark, NJ 07103-2757 Ph: (973) 972-3479 |
News Archive
Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (IS). The goal of the ISWG is to improve patient outcomes by creating protocols that educate pediatricians on early diagnosis and treatment options. Full details of this study appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
In today's headlines, reports that New York seniors are experiencing reduced prescription coverage and more California patients are being added to the health insurance rolls.
Ashoka and Boehringer Ingelheim announced today that they will launch a three-year global initiative to improve health in communities around the world. The "Making More Health" initiative will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems.
Scientists at the Research Institute of McGill University Health Centre have discovered a new genetic mutation linked to osteonecrosis of the hip, specifically the femoral head - the spherical-shaped mass at the top of the femur.
› Verified 7 days ago
Dr. Xiaoning Joanie Zhu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 741 Broadway, Newark, NJ 07104 Phone: 973-481-1300 | |
Dr. Pankaja Achar, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 194 Clinton Ave Fl 2, Newark, NJ 07108 Phone: 973-273-1515 Fax: 973-230-0883 | |
Marc H. Lavietes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 90 Bergen St, Doc 4500, Newark, NJ 07103 Phone: 973-972-2500 Fax: 973-972-2510 | |
Dr. Hoi-wing Susanna Yim, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 | |
Tharakeswari Selvakumar, MD, PHD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 150 Bergen St # Uhi-248, Newark, NJ 07103 Phone: 973-972-6056 | |
Dr. Epifania Lopez Ramirez, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1119 Broad St, Newark, NJ 07114 Phone: 973-824-8226 Fax: 973-824-0193 |